Riddle MC - Search Results

1

Determinants of weight gain in the action to control cardiovascular risk in diabetes trial.

Fonseca V, McDuffie R, Calles J, Cohen RM, Feeney P, Feinglos M, Gerstein HC, Ismail-Beigi F, Morgan TM, Pop-Busui R, Riddle MC; ACCORD Study Group. Fonseca V, et al. Among authors: riddle mc. Diabetes Care. 2013 Aug;36(8):2162-8. doi: 10.2337/dc12-1391. Epub 2013 Feb 14. Diabetes Care. 2013. PMID: 23412077 Free PMC article. Clinical Trial.

2

Current oral agents for type 2 diabetes. Many options, but which to choose when?

Ahmann AJ, Riddle MC. Ahmann AJ, et al. Among authors: riddle mc. Postgrad Med. 2002 May;111(5):32-4, 37-40, 43-6. doi: 10.3810/pgm.2002.05.1194. Postgrad Med. 2002. PMID: 12040862 Review.

3

Evolving approaches to intensive insulin therapy in type 1 diabetes: multiple daily injections, insulin pumps and new methods of monitoring.

Stephens E, Riddle M. Stephens E, et al. Rev Endocr Metab Disord. 2003 Dec;4(4):325-34. doi: 10.1023/a:1027345927676. Rev Endocr Metab Disord. 2003. PMID: 14618017 Review. No abstract available.

4

What to do when two oral agents fail to control type 2 diabetes--a matter of opinion or a matter of fact?

Ahmann AJ, Riddle MC. Ahmann AJ, et al. Among authors: riddle mc. Am J Med. 2004 Feb 15;116(4):276-8. doi: 10.1016/j.amjmed.2003.11.012. Am J Med. 2004. PMID: 14969657 No abstract available.

5

Type 2 diabetes: the role of basal insulin therapy.

LeRoith D, Levetan CS, Hirsch IB, Riddle MC. LeRoith D, et al. Among authors: riddle mc. J Fam Pract. 2004 Mar;53(3):215-22. J Fam Pract. 2004. PMID: 15000929 No abstract available.

6

Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes.

Janka HU, Plewe G, Riddle MC, Kliebe-Frisch C, Schweitzer MA, Yki-Järvinen H. Janka HU, et al. Among authors: riddle mc. Diabetes Care. 2005 Feb;28(2):254-9. doi: 10.2337/diacare.28.2.254. Diabetes Care. 2005. PMID: 15677775 Clinical Trial.

7

Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea.

Kendall DM, Riddle MC, Rosenstock J, Zhuang D, Kim DD, Fineman MS, Baron AD. Kendall DM, et al. Among authors: riddle mc. Diabetes Care. 2005 May;28(5):1083-91. doi: 10.2337/diacare.28.5.1083. Diabetes Care. 2005. PMID: 15855571 Clinical Trial.

8

Exenatide elicits sustained glycaemic control and progressive reduction of body weight in patients with type 2 diabetes inadequately controlled by sulphonylureas with or without metformin.

Riddle MC, Henry RR, Poon TH, Zhang B, Mac SM, Holcombe JH, Kim DD, Maggs DG. Riddle MC, et al. Diabetes Metab Res Rev. 2006 Nov-Dec;22(6):483-91. doi: 10.1002/dmrr.646. Diabetes Metab Res Rev. 2006. PMID: 16634116 Clinical Trial.

9

Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Gerstein HC, Riddle MC, Kendall DM, Cohen RM, Goland R, Feinglos MN, Kirk JK, Hamilton BP, Ismail-Beigi F, Feeney P; ACCORD Study Group. Gerstein HC, et al. Among authors: riddle mc. Am J Cardiol. 2007 Jun 18;99(12A):34i-43i. doi: 10.1016/j.amjcard.2007.03.004. Epub 2007 Apr 19. Am J Cardiol. 2007. PMID: 17599423 Clinical Trial.

10

Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention).

Origin Trial Investigators; Gerstein H, Yusuf S, Riddle MC, Ryden L, Bosch J. Origin Trial Investigators, et al. Among authors: riddle mc. Am Heart J. 2008 Jan;155(1):26-32, 32.e1-6. doi: 10.1016/j.ahj.2007.09.009. Epub 2007 Nov 26. Am Heart J. 2008. PMID: 18082485 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

229 results

Search Page